Joseph Araujo

Joseph Araujo

Directeur Général chez
CanCog Technologies, Inc.
52 ans
Health Technology
Commercial Services
Consumer Services

Profil

Joseph Araujo is the founder of CanCog Technologies, Inc., founded in 2002, serving as Chief Executive Officer since 2022.
Mr. Araujo was the founder of Karyopharm Therapeutics, Inc., founded in 2008, and served as Chief Financial Officer & Director from 2008 to 2010.
Mr. Araujo was the founder of Mindset Pharma, Inc., founded in 2019, and served as Director & Chief Science Officer.
Mr. Araujo currently holds the position of Director at Vivocore, Inc. Mr. Araujo is also a Director at Transpharmation Ltd. since 2021.
Mr. Araujo was President & Chief Executive Officer at InterVivo Solutions, Inc. from 2010 to 2023.
Mr. Araujo completed undergraduate education at the University of Toronto.

Postes actifs de Joseph Araujo

SociétésPosteDébut
Directeur Général 01/03/2022
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 16/09/2021

Anciens postes connus de Joseph Araujo

SociétésPosteFin
Directeur Général 01/03/2023
KARYOPHARM THERAPEUTICS INC. Fondateur 01/09/2010
MINDSET PHARMA INC. Fondateur -
Voir l'expérience en détail de Joseph Araujo

Formation de Joseph Araujo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

16

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Joseph Araujo
🔇